Market Cap

Kuros Biosciences AG Market Capitalization:

CHF1.08 Billion

CHF as of July 1, 2025

US$1.37 Billion

business Kuros Biosciences AG Company Profile

Kuros Biosciences AG Main Stock Listing

SIX: KURN

Market Capitalization History of Kuros Biosciences AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Kuros Biosciences AG market cap

Date Market Cap YoY Change
Jan. 1, 2025 CHF837.7 M 413.70%
Jan. 1, 2024 CHF163.1 M 178.90%
Jan. 1, 2023 CHF58.5 M -24.88%
Jan. 1, 2022 CHF77.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Kuros Biosciences AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Kuros Biosciences AG has the following listings and related stock indices.


Stock: SIX: KURN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.